Resources

On August 20th, 2024, the Ontario provincial government announced new legislation that would force the closure of most of Ontario’s 17 supervised consumption services (SCS).

To provide guidance on evidence-based strategies for the treatment of stimulant use disorders (StUDs), stimulant intoxication, and stimulant withdrawal, as well as se

This paper reports on the evaluation of the Digital Lifelines Scotland program, which provides underserved people who use/d drugs with digital devices to connect with services. 

To describe the implementation and short-term outcomes of an outpatient benzodiazepine taper protocol to treat benzodiazepine withdrawal in a substance use disorder bridge clinic.

This study characterized xylazine awareness, desire, use and exposure among people who use drugs (PWUD) in Rhode Island, US, at a local drug checking service. 

Several resources were developed collaboratively with service users, providers, research team members, and partners across Canada to mobilize the knowledge produced t

To determine if and how Supervised Consumption Sites (SCS) lower local real estate prices and attract people who use drugs (PWUD) to the area.

This alert identifies the emergence of nitazenes in the illicit drug supply.

It is unknown how many people in treatment for opioid use disorder (OUD) have naloxone, use naloxone, and what their perceptions and barriers to obtaining it are. 

This report is grounded in lived experience, and aims to provide a history of methadone therapy (MT) in the United States, to summarize the conference proceedings tha

To compare the risk for all cause and overdose mortality in people with opioid dependence during and after substitution treatment with methadone or buprenorphine and

This webinar exists to kick off the research report (linked on webinar webpage) about opioid-related toxicity deaths in homeless shelters.

This article discusses the origins of the overdose epidemic- and how it is not just the result of overprescribing in the early 2000's.

Involuntary care is permitted in BC for the treatment of substance use disorders, however there is insufficient understanding of the perspectives of people who use drugs (PWUD) on this approach, an

This study sought to trace the historical development and evolution of the concept of a public health approach to substance use in Canada through a critical review of the academic literature.

The MySafe program provides pharmaceutical-grade opioids to participants via biometric dispensing machines. This study examines program-related goals and related outcomes across time.

This is a compilation of information and recommendations for the implementation and use of SROM in OAT. 

The two main objectives are: (1) Provide comparable, valid and up-to-date data on costs and harms of substance use in Canada, and (2) to allow people to actively expl